IP Library Granted Patent US 10,314,948
Granted Patent B2
US 10,314,948 · App. 14/695,114 · Granted Jun 11, 2019

Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens

Inventors: Eugene T. Michal (San Francisco, CA); Daniel J. Lerner (Scarsdale, NY); Matthew J. Pollman (San Francisco, CA)
Assignee: The Spectranetics Coporation
A61L29/085A61K9/0024A61L29/141A61L29/16A61M25/104A61L2300/216A61L2420/02A61L2420/06A61M2025/105A61M2025/1075
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,314,948
App. No.
14/695,114
Granted
Jun 11, 2019
Kind
B2
Abstract

A method and device for local delivery of water-soluble or water-insoluble therapeutic agents to the surface of a normal or diseased body lumen is disclosed. An expandable structure of a medical disposable device, such as a balloon of a balloon catheter, is coated with an amphiphilic polymer coating comprising a therapeutic agent and an amphiphilic polymer or co-polymer. The medical disposable device is inserted into a body lumen, and expanded to contact the amphiphilic polymer coating against the body lumen. The total solubility of the polymer or co-polymer in vivo prevents any embolic hazard associated with the amphiphilic polymer coating.

Claims (30)

1. A method comprising:

applying a polymeric composition to at least a portion of an outer surface of an expandable portion of a disposable medical device,

said polymeric composition including a hydrophobic therapeutic agent, a plasticizer, and an amphiphilic polymer or co-polymer complexed with iodine,

wherein said polymeric composition is applied by dip coating.

2. The method of claim 1 , wherein the polymeric composition comprises an amphiphilic polymer or co-polymer selected from the group consisting of hydroxypropyl cellulose, poly (methyl vinyl ether-alt-maleic acid monobutyl ester), poly (methyl vinyl ether-alt-maleic acid monoethyl ester), and polyvinyl pyrrolidone.

3. The method of claim 1 , wherein the polymeric composition comprises a plasticizer selected from the group consisting of polyethylene glycol with a molecular weight below 10 K Daltons, propylene glycol, triethyl citrate, glycerol, and dibutyl sebacate.

4. The method of claim 1 , wherein the polymeric composition comprises a plasticizer at a concentration of less than 20% by weight of the at least one amphiphilic polymer or co-polymer complexed with iodine.

5. The method of claim 1 , wherein the polymeric composition comprises a wax selected from the group consisting of bees wax, camauba wax, polydimethyl siloxane, and polydimethyl siloxane derivatives.

6. The method of claim 5 , wherein the polymeric composition comprises a wax at a concentration of less than 1% by weight of said at least one amphiphilic polymer or co-polymer complexed with iodine.

7. The method of claim 1 , wherein the polymeric composition comprises a hydrophobic therapeutic agent selected from the group consisting of anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, thrombolytic agents, and combinations thereof.

8. The method of claim 1 , wherein the polymeric composition comprises a hydrophobic therapeutic agent selected from the group consisting of paclitaxel and dexamethasone acetate.

9. A method of coating a medical disposable device comprising:

providing a medical disposable device having an expandable portion; and forming an amphiphilic polymer coating on an outer surface of said expandable portion, said amphiphilic polymer coating including:

an amphiphilic polymer or co-polymer complexed with iodine; a hydrophobic therapeutic agent; and

a wax selected from the group consisting of bees wax, camauba wax, poly dimethyl siloxane, and polydimethyl siloxane derivatives.

10. The method of claim 9 , wherein said amphiphilic polymer or co-polymer is selected from the group consisting of hydroxypropyl cellulose, poly (methyl vinyl ether-alt-maleic acid monobutyl ester), poly (methyl vinyl ether-alt-maleic acid monoethyl ester), and polyvinyl pyrrolidone.

11. The method of claim 9 , wherein said wax is at a concentration of less than 1% by weight of said amphiphilic polymer or co-polymer complexed with iodine.

12. The method of claim 9 , wherein said amphiphilic polymer coating further comprises a plasticizer selected from the group consisting of polyethylene glycol with a molecular weight below 10 K Daltons, propylene glycol, triethyl citrate, glycerol, and dibutyl sebacate.

13. The method of claim 12 , wherein said plasticizer is at a concentration of less than 20% by weight of said amphiphilic polymer or co-polymer complexed with iodine.

14. The method of claim 9 , wherein said hydrophobic therapeutic agent is selected from the group consisting of anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, thrombolytic agents, and combinations thereof.

15. The method of claim 9 , wherein said hydrophobic therapeutic agent is selected from the group consisting of paclitaxel and dexamethasone acetate.

16. The method of claim 9 , wherein forming said amphiphilic polymer coating comprises dip coating said medical disposable device in a coating solution utilizing a single dip.

17. The method of claim 9 , wherein said amphiphilic polymer coating is substantially uniform over said outer surface, and said coating solution has a viscosity of 5 cps to 75 cps.

18. A method comprising:

applying a polymeric composition to at least a portion of an outer surface of an expandable portion of a disposable medical device, said polymeric composition including:

a hydrophobic therapeutic agent selected from the group consisting of anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, thrombolytic agents, and combinations thereof,

a plasticizer selected from the group consisting of polyethylene glycol with a molecular weight below 10 K Daltons, triethyl citrate, glycerol, and dibutyl sebacate, and

an amphiphilic polymer or co-polymer selected from the group consisting of hydroxypropyl cellulose, poly (methyl vinyl ether-alt-maleic acid monobutyl ester), poly (methyl vinyl ether-alt-maleic acid monoethyl ester), and polyvinyl pyrrolidone,

said amphiphilic polymer or co-polymer complexed with iodine,

wherein said polymeric composition is applied by dip coating.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2017
From: MIDCAP FINANCIAL TRUST
To: THE SPECTRANETICS CORPORATION; ANGIOSCORE INC.
Reel/Frame 043518/0066 →
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2017
From: MIDCAP FINANCIAL TRUST
To: THE SPECTRANETICS CORPORATION; ANGIOSCORE INC.
Reel/Frame 043518/0142 →
SECURITY INTEREST (REVOLVER) Recorded Dec 11, 2015
From: THE SPECTRANETICS CORPORATION
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037269/0425 →
SECURITY INTEREST (TERM) Recorded Dec 11, 2015
From: THE SPECTRANETICS CORPORATION
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037269/0506 →
SECURITY INTEREST Recorded Jul 2, 2015
From: THE SPECTRANETICS CORPORATION
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 036055/0156 →
Continuity (4)
Continuation 14149862 · Jan 8, 2014
Continuation 13560538 · Jul 27, 2012
Division 12210344 · Sep 15, 2008
Related Publication 20150224229A1 · Aug 13, 2015